24 /100
LOW RISK
Score updated May 28, 2026

BMYMP — Bristol-Myers Squibb Co Dilution Risk Tracker

Track BMYMP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BMYMP — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BMYMP.
🔔 Track BMYMP — Get forecast alerts →

💹 Market Data

Market CapN/A
Shares Outstanding1.64B
FloatN/A
Cash$9.74B
Debt$44.46B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 7.3% shares (2025Q4 vs prior)
2414 institutional holders · 1.75B shares
#1 VANGUARD GROUP INC 198.73M shares
#2 BlackRock, Inc. 176.83M shares
#3 STATE STREET CORP 97.98M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2
Days to Cover1000.0
% of FloatN/A
FINRA data as of Jan 15, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track BMYMP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BMYMP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for BMYMP
📊 BMYMP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BMYMP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.